CHEBI:28175 - β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer ChEBI ID CHEBI:28175 ChEBI ASCII Name beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer Definition A sialotetraosylceramide consisting of a branched hexasaccharide made up from two sialyl residues, two galactose residues, one N-acetylglucosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a β-linkage. Stars This entity has been manually annotated by the ChEBI Team. Secondary ChEBI IDs CHEBI:21150, CHEBI:5209 Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C67H113N4O39R Net Charge 0 Average Mass (excl. R groups) 1598.61750 Monoisotopic Mass (excl. R groups) 1597.69819 SMILES [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H](CO)[C@@H](O)[C@]1([H])O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@@H]1[C@@H](O)[C@@H](O[C@H](CO)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H]1NC(C)=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](OC[C@H](NC([*])=O)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@@H]1CO)C(O)=O)C(O)=O)[C@H](O)[C@H](O)CO Metabolite of Species Details Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed Roles Classification Biological Role(s): mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). (via beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer ) View more via ChEBI Ontology ChEBI Ontology Outgoing β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) has part α-Neup5Ac-(2→8)-α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-β-D-Glcp-yl group (CHEBI:142532) β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) has role mouse metabolite (CHEBI:75771) β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) is a sialotetraosylceramide (CHEBI:36543) β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) is conjugate acid of β-Gal-(1→3)-β-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-Gal-(1→4)-β-Glc-(1↔1')-Cer(2−) (CHEBI:87785) Incoming β-Gal-(1→3)-β-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-Gal-(1→4)-β-Glc-(1↔1')-Cer 1II'',9II'-lactone (CHEBI:68661) has functional parent β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) β-Gal-(1→3)-β-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-Gal-(1→4)-β-Glc-(1↔1')-Cer(d18:1/18:0) (CHEBI:90238) is a β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) β-Gal-(1→3)-β-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-Gal-(1→4)-β-Glc-(1↔1')-Cer(2−) (CHEBI:87785) is conjugate base of β-D-Gal-(1→3)-β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28175) IUPAC Name (2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→8)-5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-[β-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→4)]-β-D-galactopyranosyl-(1→4)-β-D-glucopyranoside Synonyms Sources (Gal)2 (GalNAc)1 (Glc)1 (Neu5Ac)2 (Cer)1 KEGG GLYCAN β-Galp-(1→3)-β-GalpNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-Galp-(1→4)-β-Glcp-(1↔1')-Cer ChEBI disialo GD1b ChEBI disialoganglioside GD1b ChEBI Gal(β1-3)GalNAc(β1-4)[NeuAc(α2-8)NeuAc(α2-3)]Gal(β1-4)Glc(β1-1)Cer ChEBI Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer KEGG COMPOUND Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)LacCer KEGG COMPOUND Galβ1-3GalNAcβ1-4(NeuAcα2-8NeuAcα2-3)Galβ1-4Glcβ1-1Cer ChEBI Galβ1→3GalNAcβ1→4(NeuAcα2→8NeuAcα2→3)Galβ1→4Glcβ1-1Cer ChEBI ganglioside GD1b ChEBI GD1b KEGG COMPOUND II(3)(Neuaca2-8NeuAc)Gg4Cer ChemIDplus II(3)Neu5Ac2GgOse4Cer ChemIDplus Manual Xrefs Databases C06141 KEGG COMPOUND G00115 KEGG GLYCAN LMSP0601AQ00 LIPID MAPS View more database links Registry Numbers Types Sources 10056853 Reaxys Registry Number Reaxys 19553-76-5 CAS Registry Number ChemIDplus Citations Types Sources 10949532 PubMed citation Europe PMC 1371229 PubMed citation Europe PMC 1567198 PubMed citation Europe PMC 16341241 PubMed citation Europe PMC 1724444 PubMed citation Europe PMC 17855742 PubMed citation Europe PMC 19221437 PubMed citation Europe PMC 19726417 PubMed citation Europe PMC 2303428 PubMed citation Europe PMC 2448252 PubMed citation Europe PMC 24841627 PubMed citation Europe PMC 25748038 PubMed citation Europe PMC 25867522 PubMed citation Europe PMC 26050638 PubMed citation Europe PMC 27485170 PubMed citation Europe PMC 27938 PubMed citation Europe PMC 28188832 PubMed citation Europe PMC 28416698 PubMed citation Europe PMC 6204642 PubMed citation Europe PMC 7534889 PubMed citation Europe PMC 7691279 PubMed citation Europe PMC 7693874 PubMed citation Europe PMC 8857725 PubMed citation Europe PMC Last Modified 07 December 2018